People stay on PrEP for 14 months on average in the US, study finds
Are CD4 counts still useful in the 'treat all' era?
Multiple benefits to scaling up universal test and treat in Africa
Long-acting injectable treatment maintains viral suppression
‘Molecular scissors’ successfully remove HIV genes from all tissues in infected monkeys
Integrase inhibitor treatment leads to greater weight gain
How many people who have used PrEP get HIV the same year? New York study finds out
Chronic obstructive pulmonary disease (COPD) increases the risk of heart attack in people with HIV
The length of time Americans with HIV remain infectious is falling, but slowly
